Product Information
COMPRO 25 MG SUPPOSITORY is a brand (anda) product labeled by Padagis US LLC, priced at $6.7423 per EA under NDC 00574722612. Its NADAC has been published 660 times since Nov 28, 2013.
FDA first approved this application on Jun 28, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Padagis US LLCNDC
00574722612
Classification
Brand (ANDA)
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
PROCHLORPERAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA040246FDA Approved
6/28/2000
TE Code
AB
On Market Since
9/1/2000
Pharmacological Classes
Price Statistics
The NADAC for COMPRO 25 MG SUPPOSITORY has been published 660 times since Nov 28, 2013, and over the history we have for it it has declined 15.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.7423 per EA |
|---|---|
| All-time high | $9.2396 (May 13, 2015) |
| All-time low | $4.8108 (Feb 19, 2025) |
| 52-week high | $6.7423 |
| 52-week low | $5.2327 |
| Median price | $7.1664 |
| Average price | $7.0667 |
| Largest weekly change | +24.0% (Oct 20, 2021) |
| Weeks tracked | 660 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PROCHLORPERAZINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PROCHLORPERAZINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COMPRO 25 MG SUPPOSITORY?
The current National Average Drug Acquisition Cost (NADAC) for COMPRO 25 MG SUPPOSITORY, manufactured by Padagis US LLC, is $6.7423 per EA (NDC 00574722612), effective Sep 30, 2026.
How has the price of COMPRO 25 MG SUPPOSITORY changed over time?
Over the history we have for it, the NADAC for COMPRO 25 MG SUPPOSITORY has declined 15.8%. It has been tracked across 660 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for COMPRO 25 MG SUPPOSITORY?
Since Nov 28, 2013, the NADAC for COMPRO 25 MG SUPPOSITORY has ranged from a low of $4.8108 (Feb 19, 2025) to a high of $9.2396 (May 13, 2015), with a median of $7.1664 per EA.
Are there cheaper alternatives to COMPRO 25 MG SUPPOSITORY?
No other NADAC-published product currently shares the active ingredient and strength of COMPRO 25 MG SUPPOSITORY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COMPRO 25 MG SUPPOSITORY?
COMPRO 25 MG SUPPOSITORY (NDC 00574722612) is labeled by Padagis US LLC, and CMS classifies it as a brand (anda) product.